http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2777699-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_547e7e5755fa4e9df667e286cf0511a1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69dfb911a94960883c6b53ac706a9533
publicationDate 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2777699-B1
titleOfInvention Diethylamine-2,5-dihydroxybenzenesulfonate for the treatment of age-related macular degeneration
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019110416-A1
priorityDate 2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90401981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID240950368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226584000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15548711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17507
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17506

Total number of triples: 24.